Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#110 of 589

Paul Choi

Goldman Sachs · Equity Research Analyst
ProvisionalRating since 2021No new ratings since Nov 2025

Analyst rating accuracy & track record

Paul Choi is an equity research analyst at Goldman Sachs. Quantellect has scored 20 of their stock calls across 10 companies. Their picks beat their sector 52% of the time over the next 12 months, and their price targets were reached 41% of the time within a year.

Win % vs sector
52%
PT Hit % (12mo)
41%
Avg sector-excess
+2.6%
Scored calls
20
Tickers
10
Tier
Provisional

Track record

Quantellect has scored 20 of Paul Choi's stock calls across 10 companies, dating back to 2021. Their rated stocks beat their own sector 52% of the time over the next 12 months. On a typical call, a Choi pick returned +2.6% more than its sector over the following year.

Of the scored calls, 13 were bullish (Buy) and 7 were bearish (Sell). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
PTCTPTC Therapeutics Inc
Sell$50.00Nov 2025+37.3%Miss
KNSAKiniksa Pharmaceuticals Ltd
Buy$55.00Oct 2025+133.0%Hit
KNSAKiniksa Pharmaceuticals Ltd
Buy$55.00Oct 2025+133.0%Hit
KNSAKiniksa Pharmaceuticals Ltd
Buy$55.00Oct 2025+133.0%Hit
ARVNArvinas Inc
Sell$6.00Oct 2025+51.6%Miss
EXELExelixis Inc
Buy$47.00Sep 2025+20.7%Hit
AMRNAmarin Corporation PLC
Sell$12.00Jun 2025+14.6%Miss
GOSSGossamer Bio Inc
Buy$8.00May 2025−92.7%Miss
GOSSGossamer Bio Inc
Buy$7.00Apr 2025−59.4%Miss
VIRVir Biotechnology Inc
Buy$21.00Apr 2025+77.4%Miss
AMRNAmarin Corporation PLC
Sell$7.00Apr 2025−42.6%Miss
LNTHLantheus Holdings Inc
Buy$143.00Dec 2024−44.4%Miss
GOSSGossamer Bio Inc
Buy$8.00Jun 2024+135.8%Miss
GOSSGossamer Bio Inc
Buy$8.00Mar 2024−15.6%Miss
KNSAKiniksa Pharmaceuticals Ltd
Buy$32.00Jul 2023+27.6%Miss
AMRNAmarin Corporation PLC
Sell$1.00Jul 2023+40.7%Hit
FHTXFoghorn Therapeutics Inc
Buy$19.00Jun 2023−29.9%Miss
AMRNAmarin Corporation PLC
Sell$1.50May 2022+8.0%Hit
PMVPPmv Pharmaceuticals Inc
Buy$43.00Sep 2021−55.0%Miss
AMRNAmarin Corporation PLC
Sell$5.00May 2021+75.8%Hit
Prev1Next
Go to

Paul Choi: analyst track record FAQ

Is Paul Choi a good stock analyst?

Yes, by track record. Paul Choi ranks number 110 of 589 of the analysts Quantellect scores, with an Analyst Score of 58 out of 100. Past results do not guarantee future ones.

What is Paul Choi's win rate?

Paul Choi's win rate is 52%. Across 20 scored calls, their rated stocks beat their sector 52% of the time over the next 12 months. On a typical call they returned +2.6% more than the sector.

What stocks and sectors does Paul Choi cover?

Paul Choi covers 10 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Paul Choi's price targets accurate?

Paul Choi's price targets are reached within 12 months 41% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Paul Choi's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Paul Choi rank among Wall Street analysts?

Paul Choi ranks number 110 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.